Glaucoma comprises a heterogeneous group of diseases that have in common a
characteristic optic neuropathy and visual field defects, for which elevated intraocular …

The safety profile of the different glaucoma medications is an important issue when initiating
therapy in glaucomatous patients. The decision on which medication to prescribe depends …

Numerous systemically used drugs are involved in drug-induced glaucoma. Most reported
cases of non-steroidal drug-induced glaucoma are closed-angle glaucoma (CAG). Indeed …

Glaucoma is a progressive optic neuropathy with primary and secondary forms. Iatrogenic
glaucoma secondary to medications is potentially blinding but preventable. Most drug …

Aim Our goal is to review current literature regarding drug-induced acute angle-closure
glaucoma (AACG) and provide ophthalmologists and general practitioners with a thorough …

The primary features of glaucomatous optic neuropathy are characteristic changes in the
optic nerve head, a decrease in number of surviving ganglion cells and a reduction in vision …

This review presents the pharmacotherapeutic approaches available in the treatment of
glaucomatous optic neuropathy. Although its etiology is multi-factorial, currently, the main …

Glaucoma is a chronic, progressive disease in which retinal ganglion cells disappear and
subsequent, gradual reductions in the visual field ensues. Glaucoma eye drops have …

Glaucoma is a leading cause of irreversible blindness in the world. Currently, glaucoma is
diagnosed as a progressive optic neuropathy with characteristic optic disc and nerve fiber …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …